Site icon OncologyTube

Few Therapeutic MDS Options for Patients Incorporating novel agents on trials in the right time

Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Few Therapeutic MDS Options for Patients Incorporating novel agents on trials in the right time at Imedex Great Debates 2018.

Exit mobile version